<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://www.indeelabs.com/articles</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-18</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/sequential-multiplex-editing-with-hydropore-enables-universal-armored-car-t-therapies</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-18</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/cb183da5-6c78-4761-b9c4-c000bd8d6ec5/fig+3.jpg</image:loc>
      <image:title>Articles - Sequential Multiplex Editing with Hydropore Enables Universal Armored CAR-T Therapies - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/2cbe4460-e490-449c-a8a2-a8fc5f5efb3d/fig+4.jpg</image:loc>
      <image:title>Articles - Sequential Multiplex Editing with Hydropore Enables Universal Armored CAR-T Therapies - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/2bfa5152-7df3-4466-9cc1-b7ce0c670750/fig+1.jpg</image:loc>
      <image:title>Articles - Sequential Multiplex Editing with Hydropore Enables Universal Armored CAR-T Therapies - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/40881d8d-0b7f-4e49-85c2-f869f91f43a9/1+.jpg</image:loc>
      <image:title>Articles - Sequential Multiplex Editing with Hydropore Enables Universal Armored CAR-T Therapies - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/microfluidic-vortex-shedding-enhances-genome-edited-chimeric-antigen-receptor-t-cell-function-sz8fp</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-11-06</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/c1d96c4b-751e-44a4-bc14-879fc95bd575/hydroporated+cells.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 4. Hydroporated cells showed reduced AICD and improved motility when compared with nucleofected cells. Activation-induced cell death and cell motility upon target cell engagement for hydroporated cells (red) and nucleofected cells (green) across 5 donors. Showing % of AICD at different ratios of effector cells to target cells at either (a) 1E:1T, (b) 1E:2+T, (c) 1E:1+T and (d) summary E:T ratios. Motility during synapse at (e) 1E:1T, (f) 1E:2T, (g) 1E:2T, and (h) motility summary for different targets and E:T ratios.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/a5210622-0d9f-4bfc-bc11-b21b5b383db4/figure+5.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 5. Hydroporated cells showed reduced perturbation of cytokine profiles. Volcano plot depicting resting T cell cytokine secretion fold changes and P values for supernatants collected 24 hours after processing (a) hydroporated TCR knockout, (b) nucleofected TCR knockout, c) hydroporated AAV CAR-T knock-in and (d) nucleofected AAV CAR-T knock-in. (e) summary of up/down regulated proteins relative to the NTC.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1a69e070-1a95-4017-acc7-1ef4f7e37b62/timing+assay.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 2. Image showing cells within the TIMING assay nanowells. CAR-T effector cells (green) and NALM6 target cells (orange) in TIMING assay nanowells at various effector-to-target cell ratios (E:T) at t=0.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1bf8e02a-89a2-4cc1-a32f-fe8d1196759f/1.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 1. CAR-T cells transfected via hydroporation showed improved viability, proliferation, and EGFPR+ cells. (a) viability of cells vs days post-transfection, (b) number of viable cells vs days post-transfection, and (c) number of EGFR+ cells when transfected by either hydroporation or nucleofection. (d) cytotoxicity at different effector-to-target cell ratios.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/e97dd15c-edd7-4703-bfde-79a77364ada6/figure+6.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 6. Hydroporated cells showed a significant change in cytokine profiles when directly compared to nucleofected cells. Volcano plot depicting resting T cell cytokine secretion fold changes and P values for supernatants collected at 24 hours (a) nucleofected cells vs hydroporated cells in NTC, (b) nucleofected cells vs hydroporated cells in TRC KO treated cells and c) nucleofected cells vs hydroporated cells in TRC KI treated cells. (d) summary of up/down regulated proteins relative to hydroporated cells.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/4bd35393-7d3e-4619-82f0-cdb21e08369c/figure+7.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 7. Hydroporated CAR-T cells showed a significant difference in cytokine profiles compared to nucleofected CAR-T cells. Volcano plot depicting resting T cell cytokine secretion fold changes and P values for supernatants collected at 24 hours (a) nucleofected vs hydroporated CAR-T cells at a 1:1 E:T ratio, (b nucleofected vs hydroporated CAR-T cells at a 1:2 E:T ratio,  (c) nucleofected vs hydroporated CAR-T cells at a 1:4 E:T ratio (d) nucleofected vs hydroporated CAR-T cells at a 1:8 E:T ratio. (e) heat map showing significant differences in up and down-related protein changes in hydroporated CAR-T cells vs nucleofected CAR-T cells.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/ee54402d-84d7-4d6b-adba-cf1336493d9a/car-t+cells.png</image:loc>
      <image:title>Articles - Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function - Make it stand out</image:title>
      <image:caption>Figure 3. CAR-T cells modified through hydroporation showed no significant differences in tSeek, tContact and tTarDeath values when compared to nucleofected cells. Time-based measurements of T cell target engagement of hydroporated cells (red) and nucleofected cells (green), including (a) time to synapse formation, (b) duration of synapse formation, (c) time to target cell death, (d) percentage of synapse formation, (e) percentage of spontaneous T cell death, and (f) percentage of target cell lysis with one or more target cells.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/automating-primary-human-t-cell-culture</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-07-10</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/db41e81d-1bcb-47d0-89b6-4b078e0df463/Screen+Shot+2023-07-10+at+10.03.29+AM.png</image:loc>
      <image:title>Articles - Automating Primary Human T cell Culture - Make it stand out</image:title>
      <image:caption>Figure 1 Overview of the automated cell culture work cell and software platform.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/cab41b28-c9f5-4db9-8d60-d3ec54a87281/Yellow+and+Black+Text+Safety+Yard+Sign.png</image:loc>
      <image:title>Articles - Automating Primary Human T cell Culture - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/16191062-8a39-492c-aacd-6238c36c92b7/Screen+Shot+2023-06-28+at+2.39.18+PM.png</image:loc>
      <image:title>Articles - Automating Primary Human T cell Culture - Make it stand out</image:title>
      <image:caption>Figure 2 Results comparing automated and manual T cell culture and passaging.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/cyclic-peptide-screening</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-06-29</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/2d85df41-7b32-4cd9-ad67-4cc55e4105b1/Screen+Shot+2023-05-24+at+4.44.23+PM.png</image:loc>
      <image:title>Articles - Screening Cyclic Peptides With Hydropore - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/9d5d000e-71dc-4cae-b968-9dd1f7ad0c8e/Picture1.png</image:loc>
      <image:title>Articles - Screening Cyclic Peptides With Hydropore - Make it stand out</image:title>
      <image:caption>Figure 1 A short window of cell permeability after Hydropore-processing.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/e320f973-5573-4bb2-9536-51ec220daa19/Picture3.png</image:loc>
      <image:title>Articles - Screening Cyclic Peptides With Hydropore - Make it stand out</image:title>
      <image:caption>Figure 3 Screening of additional peptides.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/e94fe5e7-7a38-42a2-a286-ac46262129f9/Picture2.png</image:loc>
      <image:title>Articles - Screening Cyclic Peptides With Hydropore - Make it stand out</image:title>
      <image:caption>Figure 2 Overview of the DµVS system.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/introducing-hydropore-for-cell-biology-and-cell-therapy-research</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623105231946-BK566SASSGVLCF7S8E3P/HERO+ANGLE+%281%29.jpg</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623253811293-QMSLNWBJ7YQRS3S3DRAE/Figure-3-Transfection-Steps.png</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Figure 3 Hydropore™ transfection protocol</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623109743916-A0Y37Z6PHKOA4KHUPVVO/Figures-Large-Whitepaper.png</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Table 1 Comparison of Hydropore™ to an RUO electroporation system. Assumes 100 µl cuvette and 50 million to 100 million cells per mL.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623109766294-6JSXTJER3V2N94PF3LO6/Table-2-Large-Whitepaper.png</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Table 2 Cost comparison per experiment of Hydropore™ to an RUO electroporation system. Assumes 100 µl cuvette and 50 million cells per mL.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623169869800-6MJW1KFDUQHXYAURNBX4/Figure-2-Hydopore-Processing.png</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Figure 2 Workflow comparison of Hydropore™ to an RUO electroporation system.</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1623112018347-3VGXKXTNTNU103BNB8XF/uVS_Illustration.png</image:loc>
      <image:title>Articles - Introducing Hydropore™ for Cell Biology &amp;amp; Cell Therapy Research - Make it stand out</image:title>
      <image:caption>Figure 1 Illustration of the µVS intracellular delivery mechanism</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/the-problem-with-gene-modified-cell-therapy-manufacturing</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612894971311-C1N8KZRHTUN45T9LYSTD/uVS-enables-gene-delivery.png</image:loc>
      <image:title>Articles - The Problem with Gene-Modified Cell Therapy Manufacturing</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612894914635-1T713DDSCE0HE7ZRGC52/GMCT.png</image:loc>
      <image:title>Articles - The Problem with Gene-Modified Cell Therapy Manufacturing</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/what-is-microfluidic-vortex-shedding</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612839258930-9QB6KYT4KNRRN7V14UZM/Plot-1.png</image:loc>
      <image:title>Articles - What Is Microfluidic Vortex Shedding?</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612839789352-6K5O7XC228CKS4HH8BJZ/Transient-Simulated-Instantenous-Flow-Field.png</image:loc>
      <image:title>Articles - What Is Microfluidic Vortex Shedding?</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612839375022-FE8OKVZ2JKYCX57FHV5K/Vortex-Shedding-Regime.png</image:loc>
      <image:title>Articles - What Is Microfluidic Vortex Shedding?</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612839757916-Q34OLHCYDJLNA9KL7IMX/Contour-plot.png</image:loc>
      <image:title>Articles - What Is Microfluidic Vortex Shedding?</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612839670315-38PKNFJIRHFPD5B3WWW3/Instantaneous-Vorticity-Contours.png</image:loc>
      <image:title>Articles - What Is Microfluidic Vortex Shedding?</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/the-limitations-and-challenges-of-cancer-therapies</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612840382081-8XBD4L4YZ7UX5SIMH83Z/LCT-1.png</image:loc>
      <image:title>Articles - The Limitations and Challenges of Cancer Therapies</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1612840346136-M9XNII718NYYR0O5Y217/LCT-2.png</image:loc>
      <image:title>Articles - The Limitations and Challenges of Cancer Therapies</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/new-cell-contenders-in-the-car-field-part-two</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1616004937559-CKIHS5DW6VZL9ZUC4BPE/Overview-CAR-macropagegs-activation.png</image:loc>
      <image:title>Articles - New Cell Contenders in the CAR Field (Part 2)</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/new-cell-contenders-in-the-car-field-part-one</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1616004070793-NU9UUT1KRXZ7OMF57OYA/Table-Immune-Cell-Frequencies-StemcellTechnologies.png</image:loc>
      <image:title>Articles - New Cell Contenders in the CAR Field (Part 1)</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1616003933017-KH9O6VKW7E5O0AH9XP46/Overview-Immune-Cell-Types.png</image:loc>
      <image:title>Articles - New Cell Contenders in the CAR Field (Part 1)</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/articles/saving-us-from-ourselves-harnessing-the-power-of-car-t-to-combat-autoimmunity</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-30</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1616005500349-RMPDSQHWDKVGWBDTCA0I/computational-fluid-dynamic-simulation-in-chip-microfluidic-vortex-shedding.png</image:loc>
      <image:title>Articles - Saving Us from Ourselves: Harnessing the Power of CAR-T to Combat Autoimmunity</image:title>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1616005430313-NUZFP091QCK851SFL9DR/Overview-autoimmune-disease.png</image:loc>
      <image:title>Articles - Saving Us from Ourselves: Harnessing the Power of CAR-T to Combat Autoimmunity</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-05-26</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-sunko</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-26</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-scispot</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-25</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-broadoak</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-05-14</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-partners-with-genscript</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-04-12</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-partners-with-monomer-bio</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2023-02-16</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-awarded-2m-contract-to-scale-up-and-out-hydropore-for-cell-therapy</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-12-01</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/musc-immunology-researcher-receives-sbir-grant-with-indee-labs-to-push-boundaries-of-regulatory-t-cell-therapy</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-10-22</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/5e39d650-2b36-4cb4-bc76-dae0b215fa9b/Leo+Ferreira+hydropore.jpeg</image:loc>
      <image:title>News - MUSC immunology researcher receives SBIR grant with Indee Labs to push boundaries of regulatory T-cell therapy - Make it stand out</image:title>
      <image:caption>Leo Ferreira, Ph.D., is testing a more effective way to manipulate Tregs for immunotherapy, so that fewer cells are lost in the process. Photo by Clif Rhodes of Medical University of South Carolina.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-announces-successful-launch-of-early-access-program</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-11-01</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-awarded-contract-from-the-national-cancer-institute</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-05-11</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-awarded-grant-from-the-national-institute-of-allergy-and-infectious-disease</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-05-11</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/news/indee-labs-crispr-delivery-technology-for-affordable-immunotherapies</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-05-11</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1611875100818-UO4EY224METB55HT9YA7/Synthego-Crispr-Cuts-Ryan-Pawell-Indee-Labs</image:loc>
      <image:title>News - Indee Lab’s CRISPR Delivery Technology for Affordable Immunotherapies</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2023-07-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1615920611733-7UF9AO5XRFA829UDOF9Q/Indee-Labs-Partners.jpg</image:loc>
      <image:title>Home</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/media</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-01-17</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/technology</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2023-07-21</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/6008862cd4535b44c9031c71/1619723493015-YIYNT948DN0A36C0Z6O3/Graphical+Abstract.png</image:loc>
      <image:title>Technology</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.indeelabs.com/contact</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-15</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/careers</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-12-17</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/blog</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-01-17</lastmod>
  </url>
  <url>
    <loc>https://www.indeelabs.com/publications-patents</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-03-25</lastmod>
  </url>
</urlset>

